US EditionPublished • loading... • Updated
Emergent BioSolutions Inc. (EBS) Stock Analysis: Analyst Ratings Indicate Potential 12% Upside
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Emergent BioSolutions Inc. (EBS) Stock Analysis: Analyst Ratings Indicate Potential 12% Upside
Emergent BioSolutions Inc. (NYSE: EBS) is making waves in the healthcare sector as it navigates a complex landscape of public health preparedness. Founded in 1998 and headquartered in Gaithersburg, Maryland, Emergent BioSolutions offers a range of solutions for accidental, deliberate, and naturally occurring public health threats. The company’s diverse portfolio includes products like NARCAN Nasal Spray for opioid overdose treatment and vaccines…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
